Efflux Pump Genes of the Resistance-nodulation-division Family in Burkholderia Cenocepacia Genome

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2006 Jul 22

PMID 16857052

Citations 44

Authors

Paola Guglierame

Maria Rosalia Pasca

Edda De Rossi

Silvia Buroni

Patrizio Arrigo

Giulia Manina

Giovanna Riccardi

Affiliations

Soon will be listed here.

Abstract

Background: Burkholderia cenocepacia is recognized as opportunistic pathogen that can cause lung infections in cystic fibrosis patients. A hallmark of B. cenocepacia infections is the inability to eradicate the organism because of multiple intrinsic antibiotic resistance. As Resistance-Nodulation-Division (RND) efflux systems are responsible for much of the intrinsic multidrug resistance in Gram-negative bacteria, this study aims to identify RND genes in the B. cenocepacia genome and start to investigate their involvement into antimicrobial resistance.

Results: Genome analysis and homology searches revealed 14 open reading frames encoding putative drug efflux pumps belonging to RND family in B. cenocepacia J2315 strain. By reverse transcription (RT)-PCR analysis, it was found that orf3, orf9, orf11, and orf13 were expressed at detectable levels, while orf10 appeared to be weakly expressed in B. cenocepacia. Futhermore, orf3 was strongly induced by chloramphenicol. The orf2 conferred resistance to fluoroquinolones, tetraphenylphosphonium, streptomycin, and ethidium bromide when cloned and expressed in Escherichia coli KAM3, a strain lacking the multidrug efflux pump AcrAB. The orf2-overexpressing E. coli also accumulate low concentrations of ethidium bromide, which was restored to wild type level in the presence of CCCP, an energy uncoupler altering the energy of the drug efflux pump.

Conclusion: The 14 RND pumps gene we have identified in the genome of B. cenocepacia suggest that active efflux could be a major mechanism underlying antimicrobial resistance in this microorganism. We have characterized the ORF2 pump, one of these 14 potential RND efflux systems. Its overexpression in E. coli conferred resistance to several antibiotics and to ethidium bromide but it remains to be determined if this pump play a significant role in the antimicrobial intrinsic resistance of B. cenocepacia. The characterization of antibiotic efflux pumps in B. cenocepacia is an obligatory step prior to the design of specific, potent bacterial inhibitors for the improved control of infectious diseases. Consequently, the topic deserves to be further investigated and future studies will involve systematic investigation on the function and expression of each of the RND efflux pump homologs.

Citing Articles

Convergence of Hypervirulence and Multidrug-Resistance in Complex Isolates from Patients with COVID-19.

Du M, Chi C, Xiong L, Rong J, Yi M, Zhao Q Infect Drug Resist. 2025; 17:5855-5866.

PMID: 39741887 PMC: 11687121. DOI: 10.2147/IDR.S495676.

Novel species from human infections: improved matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based identification and analysis of antimicrobial resistance patterns.

Steyaert S, Peeters C, Wieme A, Muyldermans A, Vandoorslaer K, Spilker T Microbiol Spectr. 2024; 12(6):e0402123.

PMID: 38661349 PMC: 11237764. DOI: 10.1128/spectrum.04021-23.

Oridonin Attenuates Burkholderia cenocepacia Virulence by Suppressing Quorum-Sensing Signaling.

Li X, Wang K, Wang G, Cui B, Song S, Sun X Microbiol Spectr. 2022; 10(4):e0178722.

PMID: 35856676 PMC: 9430380. DOI: 10.1128/spectrum.01787-22.

New Auranofin Analogs with Antibacterial Properties against Clinical Isolates.

Maydaniuk D, Wu B, Truong D, Liyanage S, Hogan A, Yap Z Antibiotics (Basel). 2021; 10(12).

PMID: 34943654 PMC: 8697972. DOI: 10.3390/antibiotics10121443.

Coming from the Wild: Multidrug Resistant Opportunistic Pathogens Presenting a Primary, Not Human-Linked, Environmental Habitat.

Sanz-Garcia F, Gil-Gil T, Laborda P, Ochoa-Sanchez L, Martinez J, Hernando-Amado S Int J Mol Sci. 2021; 22(15).

PMID: 34360847 PMC: 8347278. DOI: 10.3390/ijms22158080.

References

Lyczak J, Cannon C, Pier G . Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002; 15(2):194-222. PMC: 118069. DOI: 10.1128/CMR.15.2.194-222.2002. View

Wigfield S, Rigg G, Kavari M, Webb A, Matthews R, Burnie J . Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother. 2002; 49(4):619-24. DOI: 10.1093/jac/49.4.619. View

Murakami S, Nakashima R, Yamashita E, Yamaguchi A . Crystal structure of bacterial multidrug efflux transporter AcrB. Nature. 2002; 419(6907):587-93. DOI: 10.1038/nature01050. View

Fehlner-Gardiner C, Valvano M . Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein. FEMS Microbiol Lett. 2002; 215(2):279-83. DOI: 10.1111/j.1574-6968.2002.tb11403.x. View

Morita Y, Murata T, Mima T, Shiota S, Kuroda T, Mizushima T . Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. J Antimicrob Chemother. 2003; 51(4):991-4. DOI: 10.1093/jac/dkg173. View

Aeschlimann J . The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2003; 23(7):916-24. DOI: 10.1592/phco.23.7.916.32722. View

Schweizer H . Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003; 2(1):48-62. View

Li X, Nikaido H . Efflux-mediated drug resistance in bacteria. Drugs. 2004; 64(2):159-204. DOI: 10.2165/00003495-200464020-00004. View

Nair B, Cheung Jr K, Griffith A, Burns J . Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest. 2004; 113(3):464-73. PMC: 324543. DOI: 10.1172/JCI19710. View

10.

Vogne C, Aires J, Bailly C, Hocquet D, Plesiat P . Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2004; 48(5):1676-80. PMC: 400545. DOI: 10.1128/AAC.48.5.1676-1680.2004. View

11.

Koronakis V, Eswaran J, Hughes C . Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem. 2004; 73:467-89. DOI: 10.1146/annurev.biochem.73.011303.074104. View

12.

Akama H, Matsuura T, Kashiwagi S, Yoneyama H, Narita S, Tsukihara T . Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J Biol Chem. 2004; 279(25):25939-42. DOI: 10.1074/jbc.C400164200. View

13.

Higgins M, Bokma E, Koronakis E, Hughes C, Koronakis V . Structure of the periplasmic component of a bacterial drug efflux pump. Proc Natl Acad Sci U S A. 2004; 101(27):9994-9. PMC: 454203. DOI: 10.1073/pnas.0400375101. View

14.

Wang H, Noordewier M, Benham C . Stress-induced DNA duplex destabilization (SIDD) in the E. coli genome: SIDD sites are closely associated with promoters. Genome Res. 2004; 14(8):1575-84. PMC: 509266. DOI: 10.1101/gr.2080004. View

15.

Nakamura H . Novel acriflavin resistance genes, acrC and acrD, in Escherichia coli K-12. J Bacteriol. 1979; 139(1):8-12. PMC: 216820. DOI: 10.1128/jb.139.1.8-12.1979. View

16.

Scordilis G, Ree H, LESSIE T . Identification of transposable elements which activate gene expression in Pseudomonas cepacia. J Bacteriol. 1987; 169(1):8-13. PMC: 211726. DOI: 10.1128/jb.169.1.8-13.1987. View

17.

Moore R, Hancock R . Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother. 1986; 30(6):923-6. PMC: 180620. DOI: 10.1128/AAC.30.6.923. View

18.

Parr Jr T, Moore R, Moore L, Hancock R . Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother. 1987; 31(1):121-3. PMC: 174667. DOI: 10.1128/AAC.31.1.121. View

19.

Aronoff S . Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother. 1988; 32(11):1636-9. PMC: 175943. DOI: 10.1128/AAC.32.11.1636. View

20.

Burns J, Lien D, Hedin L . Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia. Antimicrob Agents Chemother. 1989; 33(8):1247-51. PMC: 172634. DOI: 10.1128/AAC.33.8.1247. View